Metagenomic next-generation sequencing improves diagnosis of <i>Talaromyces marneffei</i> and mixed infections in HIV/AIDS patients: a retrospective study.

← Research Home← More in this subcategory
Europe PMCPublished 2026Public Health & EpidemiologyPopulation Health & Disease Prevention
Journal
Frontiers in medicine
Record source
Europe PMC Research Library

Abstract / Description

BackgroundOpportunistic infections remain a leading cause of morbidity in people living with HIV (PLWH). Talaromyces marneffei (T. marneffei) accounts for up to 15% of HIV-related hospitalizations in endemic regions. Metagenomic next-generation sequencing (mNGS) offers rapid pathogen detection; however, its utility in diagnosing HIV-associated coinfections is uncertain.MethodsThis retrospective study enrolled 56 hospitalized PLWH with coinfections at the Third Affiliated Hospital of Sun Yat-sen University from March 2022 to October 2024. All patients underwent pathogen detection using both mNGS and CTM, with their diagnostic performance compared. Clinical data, treatment adjustments, and outcomes were analyzed.ResultsmNGS demonstrated significantly higher detection rate (84.4%, 54/64; 95% CI: 73.1-92.2%) than CTM (28.1%, 18/64; 95% CI: 17.6-40.8%; p 
Read original research ↗Open DOI ↗